Private Equity

TW Pengu Holdings Limited

A premier private oncology and oncology-related clinic group in Asia

OncoCare Medical (“OncoCare”) is one of the largest private medical oncology specialist centers in Singapore, offering a one-stop solution for both local and foreign patients. OncoCare provides comprehensive diagnosis, treatment, palliative care, and other medical services with its team of specialized medical oncologists and palliative specialists.

Icon Cancer Centre Hong Kong ("Icon HK") is a premium oncology cancer center group in Hong Kong, with 3 clinics in prime locations, providing a full suite of oncology services across various cancer types, including medical oncology, radiation oncology, wholesale pharmacy, and colorectal surgical services.

Novena Heart Centre (“NHC”) is one of the largest multi-disciplinary cardiology group practices in Singapore, specializing in coronary intervention, heart rhythm management, heart failure, cardiac imaging, and cardiothoracic surgery.

Singapore Breast Surgery Center (“SBSC”) is an integrated breast cancer care group in Singapore, operating under the brands Solis and Luma, covering the entire breast cancer theragnostic process, including screening, diagnostic imaging, pathology and surgery services.

Central Luzon Integrated Oncology Center (“CLIOC”) is a leading oncology clinic located in Mother Teresa of Calcutta Medical Center in San Fernando, Philippines, providing tomotherapy and chemotherapy services.

Can-Care is retailer and distributor of post-cancer care products, operating out of four retail outlets in Singapore and Malaysia as well as 22 distributor outlets.

TW Pengu Holdings Limited
Sector
Healthcare
Country
Asia
Fund
Private Equity
Entry
2023
Type
Control
Website
Website
GO TO WEBSITE

About

TW Pengu Holdings Limited

TW Pengu Holdings Limited is a buy-and-build strategy aimed at creating a leading oncology and oncology related group in Asia through organic expansion, bolt-on acquisitions and partnerships in Southeast Asia and Hong Kong.

Investment Highlights

TW Pengu Holdings Limited is a premier oncology and oncology-related clinic group in Asia, encompassing key entities such as OncoCare, NHC, Icon HK, SBSC, CLIOC, and Can-Care. OncoCare and NHC hold strong market positions in Singapore, offering comprehensive oncology and cardiology services. Icon HK is a premium oncology group in Hong Kong, offering a full range of oncology services, including medical and radiation oncology. SBSC, operating under the Solis and Luma brands, provides integrated breast cancer care and is a renowned institution in Singapore. CLIOC is a leading oncology clinic in the Philippines, while Can-Care supports post-cancer care in Singapore and Malaysia. With the growing demand for specialized healthcare services driven by an aging population and preventive healthcare trends, TW Pengu Holdings Limited is well-positioned to capitalize on these opportunities.

Templewater is committed to organic and strategic growth through joint ventures and acquisitions, aiming to expand services regionally in Southeast Asia and Hong Kong.

Private Equity

TW Pengu Holdings Limited

A premier private oncology and oncology-related clinic group in Asia

OncoCare Medical (“OncoCare”) is one of the largest private medical oncology specialist centers in Singapore, offering a one-stop solution for both local and foreign patients. OncoCare provides comprehensive diagnosis, treatment, palliative care, and other medical services with its team of specialized medical oncologists and palliative specialists.

Icon Cancer Centre Hong Kong ("Icon HK") is a premium oncology cancer center group in Hong Kong, with 3 clinics in prime locations, providing a full suite of oncology services across various cancer types, including medical oncology, radiation oncology, wholesale pharmacy, and colorectal surgical services.

Novena Heart Centre (“NHC”) is one of the largest multi-disciplinary cardiology group practices in Singapore, specializing in coronary intervention, heart rhythm management, heart failure, cardiac imaging, and cardiothoracic surgery.

Singapore Breast Surgery Center (“SBSC”) is an integrated breast cancer care group in Singapore, operating under the brands Solis and Luma, covering the entire breast cancer theragnostic process, including screening, diagnostic imaging, pathology and surgery services.

Central Luzon Integrated Oncology Center (“CLIOC”) is a leading oncology clinic located in Mother Teresa of Calcutta Medical Center in San Fernando, Philippines, providing tomotherapy and chemotherapy services.

Can-Care is retailer and distributor of post-cancer care products, operating out of four retail outlets in Singapore and Malaysia as well as 22 distributor outlets.

TW Pengu Holdings Limited
Sector
Healthcare
Country
Asia
Fund
Private Equity
Entry
2023
Type
Control
Website
GO TO WEBSITE

About

TW Pengu Holdings Limited

TW Pengu Holdings Limited is a buy-and-build strategy aimed at creating a leading oncology and oncology related group in Asia through organic expansion, bolt-on acquisitions and partnerships in Southeast Asia and Hong Kong.

Investment Highlights

TW Pengu Holdings Limited is a premier oncology and oncology-related clinic group in Asia, encompassing key entities such as OncoCare, NHC, Icon HK, SBSC, CLIOC, and Can-Care. OncoCare and NHC hold strong market positions in Singapore, offering comprehensive oncology and cardiology services. Icon HK is a premium oncology group in Hong Kong, offering a full range of oncology services, including medical and radiation oncology. SBSC, operating under the Solis and Luma brands, provides integrated breast cancer care and is a renowned institution in Singapore. CLIOC is a leading oncology clinic in the Philippines, while Can-Care supports post-cancer care in Singapore and Malaysia. With the growing demand for specialized healthcare services driven by an aging population and preventive healthcare trends, TW Pengu Holdings Limited is well-positioned to capitalize on these opportunities.

Templewater is committed to organic and strategic growth through joint ventures and acquisitions, aiming to expand services regionally in Southeast Asia and Hong Kong.

Private Equity

TW Pengu Holdings Limited

A premier private oncology and oncology-related clinic group in Asia

OncoCare Medical (“OncoCare”) is one of the largest private medical oncology specialist centers in Singapore, offering a one-stop solution for both local and foreign patients. OncoCare provides comprehensive diagnosis, treatment, palliative care, and other medical services with its team of specialized medical oncologists and palliative specialists.

Icon Cancer Centre Hong Kong ("Icon HK") is a premium oncology cancer center group in Hong Kong, with 3 clinics in prime locations, providing a full suite of oncology services across various cancer types, including medical oncology, radiation oncology, wholesale pharmacy, and colorectal surgical services.

Novena Heart Centre (“NHC”) is one of the largest multi-disciplinary cardiology group practices in Singapore, specializing in coronary intervention, heart rhythm management, heart failure, cardiac imaging, and cardiothoracic surgery.

Singapore Breast Surgery Center (“SBSC”) is an integrated breast cancer care group in Singapore, operating under the brands Solis and Luma, covering the entire breast cancer theragnostic process, including screening, diagnostic imaging, pathology and surgery services.

Central Luzon Integrated Oncology Center (“CLIOC”) is a leading oncology clinic located in Mother Teresa of Calcutta Medical Center in San Fernando, Philippines, providing tomotherapy and chemotherapy services.

Can-Care is retailer and distributor of post-cancer care products, operating out of four retail outlets in Singapore and Malaysia as well as 22 distributor outlets.

TW Pengu Holdings Limited
Sector
Healthcare
Country
Asia
Fund
Private Equity
Entry
2023
Type
Website
Control
JV Partner

About

TW Pengu Holdings Limited

TW Pengu Holdings Limited is a buy-and-build strategy aimed at creating a leading oncology and oncology related group in Asia through organic expansion, bolt-on acquisitions and partnerships in Southeast Asia and Hong Kong.

Key Figures

Location
Sydney, New South Wales
Site Area
1,681 m2 (combined development site)
Asset Class
Office
Occupancy
100%
Location
Adelaide, South Australia
Gross Lettable Area
23,243 m2
Asset Class
Retail
Passing Yield
5.2% (at acquisition)
Tenants
90 (at acquisition)
Location
Melbourne, Victoria
Site Area
258,885 m2
Asset Class
Mixed-use
(Residential and Commercial)
Residences
1,000+
Location
Melbourne, Victoria
Site Area
15,745 m2
Asset Class
Office (with supporting retail)
Net Lettable Area
up to 56,000 m2 (upon completion)

Contact Us

Thank you for getting in touch,
we always try our best to respond as soon as possible,
you can expect a reply in at most 48 hours
Please try again! Something went wrong while submitting the form.